Surfactant and non invasive ventilation for preterm infants

Area of Science:

• Neonatology
• Pediatric Respiratory Medicine
• Critical Care

Background:

• Mechanical ventilation, while life-saving for preterm infants, increases the risk of Bronchopulmonary Dysplasia (BPD).
• Nasal Continuous Positive Airway Pressure (NCPAP) is an alternative to invasive ventilation but has a failure rate of approximately 30%, even with surfactant therapy.
• Non-invasive ventilation methods are crucial for preventing mechanical ventilation in neonates.

Purpose of the Study:

• To evaluate alternative non-invasive ventilation strategies in neonatology.
• To assess the efficacy of Synchronized Nasal Intermittent Positive Ventilation (SNIPPV) in preterm infants.
• To identify methods that may reduce the incidence of BPD.

Main Methods:

• Review of current non-invasive ventilation techniques used in neonatology.
• Comparison of outcomes between NCPAP and alternative methods like SNIPPV.
• Analysis of data on treatment failures and success rates for different ventilation strategies.

Main Results:

• NCPAP fails in about 30% of preterm infants, even with surfactant therapy.
• Synchronized Nasal Intermittent Positive Ventilation (SNIPPV) is presented as a potentially more effective non-invasive ventilation method.
• SNIPPV appears to yield better results compared to other non-invasive approaches.

Conclusions:

• Alternative non-invasive ventilation modes are essential for preventing mechanical ventilation in neonates.
• SNIPPV demonstrates potential as an improved non-invasive ventilation strategy for preterm infants.
• Further research into SNIPPV may lead to reduced BPD rates and better respiratory support for vulnerable neonates.